The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis
Abstract
Background: Tourette syndrome (TS) is a neurodevelopmental condition characterised by chronic motor and vocal tics affecting up to 1% of school-age children and young people and is associated with significant distress and psychosocial impairment. Objective: To conduct a systematic review of the benefits and risks of pharmacological, behavioural and physical interventions for tics in children and young people with TS (part 1) and to explore the experience of treatment and services from the perspective of young people with TS and their parents (part 2). Data Sources: For the systematic reviews (parts 1 and 2), mainstream bibliographic databases, The Cochrane Library, education, social care and grey literature databases were searched using subject headings and text words for tic* and Tourette* from database inception to January 2013. Review/research methods: For part 1, randomised controlled trials and controlled before-and-after studies of pharmacological, behavioural or physical interventions in children or young people (aged < 18 years) with TS or chronic tic disorder were included. Mixed studies and studies in adults were considered as supporting evidence. Risk of bias associated with each study was evaluated using the Cochrane tool. When there was sufficient data, random-effects meta-analysis was used to synthesize the evidence and the quality of evidence for each outcome was assessed using the Grading of Recommendations Assessment, Development and Evaluation approach. For part 2, qualitative studies and survey literature conducted in populations of children/young people with TS or their carers or in health professionals with experience of treating TS were included in the qualitative review. Results were synthesized narratively. In addition, a national parent/carer survey was conducted via the Tourettes Action website. Participants included parents of children and young people with TS aged under 18 years. Participants (young people with TS aged 10–17 years) for the in-depth interviews were recruited via a national survey and specialist Tourettes clinics in the UK. Results: For part 1, 70 studies were included in the quantitative systematic review. The evidence suggested that for treating tics in children and young people with TS, antipsychotic drugs [standardised mean difference (SMD) –0.74, 95% confidence interval (CI) –1.08 to –0.41;n = 75] and noradrenergic agents [clonidine (Dixarit®, Boehringer Ingelheim) and guanfacine: SMD –0.72, 95% CI –1.03 to –0.40;n = 164] are effective in the short term. There was little difference among antipsychotics in terms of benefits, but adverse effect profiles do differ. Habit reversal training (HRT)/comprehensive behavioural intervention for tics (CBIT) was also shown to be effective (SMD –0.64, 95% CI –0.99 to –0.29;n = 133). For part 2, 295 parents/carers of children and young people with TS contributed useable survey data. Forty young people with TS participated in in-depth interviews. Four studies were in the qualitative review. Key themes were difficulties in accessing specialist care and behavioural interventions, delay in diagnosis, importance of anxiety and emotional symptoms, lack of provision of information to schools and inadequate information regarding medication and adverse effects. Limitations: The number and quality of clinical trials is low and this downgrades the strength of the evidence and conclusions. Conclusions: Antipsychotics, noradrenergic agents and HRT/CBIT are effective in reducing tics in children and young people with TS. The balance of benefits and harms favours the most commonly used medications: risperidone (Risperdal®, Janssen), clonidine and aripiprazole (Abilify®, Otsuka). Larger and better-conducted trials addressing important clinical uncertainties are required. Further research is needed into widening access to behavioural interventions through use of technology including mobile applications (‘apps’) and video consultation. Study registration: This study is registered as PROSPERO CRD42012002059. Funding: The National Institute for Health Research Health Technology Assessment programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Regarding other types of psychological interventions, a meta-analysis by Hollis et al. [36] found no evidence for tic-specific effectiveness of relaxation training, parent training, or anger control training.”
From European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions (2022) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Using thematic analysis in psychology
Braun, V., & Clarke, V. (2006) · Qualitative Research in Psychology · doi:10.1191/1478088706qp063oa · Cited by 194,414
Habit-reversal: a method of eliminating nervous habits and tics
Azrin, N. H., & Nunn, R. G. (1973) · Behaviour Research and Therapy · doi:10.1016/0005-7967(73)90119-8 · Cited by 967
Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome
Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rašin, M.-R., Gunel, M., et al. (2005) · Science · doi:10.1126/science.1116502 · Cited by 940
Behavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial
Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., et al. (2010) · JAMA · doi:10.1001/jama.2010.607 · Cited by 790
Perlmutter, S. J., Leitman, S. F., Garvey, M. A., Hamburger, S., Feldman, E., Leonard, H. L., & Swedo, S. E. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12297-3 · Cited by 556
Treatment of ADHD in children with tics: A randomized controlled trial
The Tourette’s Syndrome Study Group (2002) · Neurology · doi:10.1212/wnl.58.4.527 · Cited by 504
the ESSTS Guidelines Group, Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0163-7 · Cited by 461
Self-citationA placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Snider, L. A., Lougee, L., Slattery, M., Grant, P., & Swedo, S. E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.035 · Cited by 237
Deckersbach, T., Rauch, S., Buhlmann, U., & Wilhelm, S. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.08.007 · Cited by 231
Research works printed but not linked: 206
- American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders. DSM-5, 10.1176/appi.books.9780890425596 · DOI · Paper page
- World Health Organization (WHO), 1992, International Classification of Diseases and Health-Related Problems
- Robertson, 1989, The Gilles de la Tourette syndrome: the current status, Br J Psychiatry, 154, 147, 10.1192/bjp.154.2.147 · DOI · Paper page
- Robertson, 1994, Annotation: Gilles de la Tourette syndrome – an update, J Child Psychol Psychiatry, 35, 597, 10.1111/j.1469-7610.1994.tb01209.x · DOI
- Robertson, 1989, Self-injurious behaviour and the Gilles de la Tourette syndrome: a clinical study and review of the literature, Psychol Med, 19, 611, 10.1017/S0033291700024211 · DOI · Paper page
- Kurlan, 1996, Non–obscene complex socially inappropriate behavior in Tourette’s syndrome, J Neuropsychiatry Clin Neurosci, 8, 311, 10.1176/jnp.8.3.311 · DOI
- Robertson, 2013, Gilles de la Tourette Syndrome: The Current Status
- Robertson, 1999, The Tourette syndrome diagnostic confidence index: development and clinical associations, Neurology, 53, 2108, 10.1212/WNL.53.9.2108 · DOI · Paper page
- Robertson, 2012, The Gilles de la Tourette syndrome: the current status, Arch Dis Child Educ Pract Ed, 97, 166, 10.1136/archdischild-2011-300585 · DOI · Paper page
- Robertson, 2008, The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: The epidemiological and prevalence studies, J Psychosom Res, 65, 461, 10.1016/j.jpsychores.2008.03.006 · DOI · Paper page
- Robertson, 2008, The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: Tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes, J Psychosom Res, 65, 473, 10.1016/j.jpsychores.2008.03.007 · DOI
- Knight, 2012, Prevalence of tic disorders: a systematic review and meta-analysis, Pediatr Neurol, 47, 77, 10.1016/j.pediatrneurol.2012.05.002 · DOI · Paper page
- Ferrao, 2013, Tourette Syndrome, 50, 10.1093/med/9780199796267.003.0003 · DOI
- Cath, 2013, Tourette Syndrome, 74, 10.1093/med/9780199796267.003.0004 · DOI
- Khalifa, 2003, Prevalence of tic disorders and Tourette syndrome in a Swedish school population, Dev Med Child Neurol, 45, 315, 10.1111/j.1469-8749.2003.tb00402.x · doi:10.1111/j.1469-8749.2003.tb00402.x · Paper page
- Mol Debes, 2008, Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome, J Child Neurol, 23, 1017, 10.1177/0883073808316370 · DOI
- Scahill, 2013, Tourette Syndrome, 121, 10.1093/med/9780199796267.003.0006 · DOI
- Robertson, 2013, Tourette Syndrome, 361, 10.1093/med/9780199796267.003.0016 · DOI
- Fernandez, 2013, Tourette Syndrome, 137, 10.1093/med/9780199796267.003.0007 · DOI
- Pauls, 1994, Evidence against a genetic relationship between Tourette’s syndrome and anxiety, depression, panic and phobic disorders, Br J Psychiatry, 164, 215, 10.1192/bjp.164.2.215 · DOI
- Robertson, 1988, The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis, Br J Psychiatry, 152, 383, 10.1192/bjp.152.3.383 · DOI · Paper page
- Robertson, 1988, Some personality variables in functional neurological disorders, Behav Neurol, 1, 23, 10.1155/1988/839812 · doi:10.1155/1988/839812
- Robertson, 1993, The psychopathology of Gilles de la Tourette’s syndrome. A controlled study, Br J Psychiatry, 162, 114, 10.1192/bjp.162.1.114 · DOI
- Robertson, 1997, Personality disorder and psychopathology in Tourette’s syndrome: a controlled study, Br J Psychiatry, 171, 283, 10.1192/bjp.171.3.283 · DOI
- Rickards, 2003, A controlled study of psychopathology and associated symptoms in Tourette syndrome, World J Biol Psychiatry, 4, 64, 10.3109/15622970309167953 · DOI
- Carter, 2000, Social and emotional adjustment in children affected with Gilles de la Tourette’s syndrome: associations with ADHD and family functioning. Attention Deficit Hyperactivity Disorder, J Child Psychol Psychiatry, 41, 215, 10.1017/S0021963099005156 · DOI · Paper page
- Robertson, 2002, Obsessive compulsive behaviour and depressive symptoms in young people with Tourette syndrome. A controlled study, Eur Child Adolesc Psychiatry, 11, 261, 10.1007/s00787-002-0301-3 · DOI
- Robertson, 2006, Behavioral and affective disorders in Tourette syndrome, Adv Neurol, 99, 39
- Sukhodolsky, 2003, Disruptive behavior in children with Tourette’s syndrome: association with ADHD comorbidity, tic severity, and functional impairment, J Am Acad Child Adolesc Psychiatry, 42, 98, 10.1097/00004583-200301000-00016 · DOI · Paper page
- Rizzo, 2007, Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes, Brain Dev, 29, 413, 10.1016/j.braindev.2006.12.003 · DOI
- Haddad, 2009, Adults with Tourette’s syndrome with and without attention deficit hyperactivity disorder, Acta Psychiatr Scand, 120, 299, 10.1111/j.1600-0447.2009.01398.x · DOI
- Elstner, 2001, Quality of Life (QOL) of patients with Gilles de la Tourette’s syndrome, Acta Psychiatr Scand, 103, 52, 10.1034/j.1600-0447.2001.00147.x · doi:10.1034/j.1600-0447.2001.00147.x · Paper page
- Cavanna, 2013, Disease-specific quality of life in young patients with tourette syndrome, Pediatr Neurol, 48, 111, 10.1016/j.pediatrneurol.2012.10.006 · DOI
- Eddy, 2012, The effects of comorbid obsessive–compulsive disorder and attention-deficit hyperactivity disorder on quality of life in tourette syndrome, J Neuropsychiatry Clin Neurosci, 24, 458, 10.1176/appi.neuropsych.11080181 · DOI · Paper page
- Robertson, 2012, A Family Guide to Tourette Syndrome, 171
- Sukhodolsky, 2013, Tourette Syndrome, 468, 10.1093/med/9780199796267.003.0021 · DOI
- Bawden, 1998, Peer relationship problems in children with Tourette’s disorder or diabetes mellitus, J Child Psychol Psychiatry, 39, 663, 10.1017/S0021963098002480 · DOI · Paper page
- Lee, 2007, Parenting stress and related factors in parents of children with Tourette syndrome, J Nurs Res, 15, 165, 10.1097/01.JNR.0000387612.85897.9a · DOI
- Cooper, 2003, Psychological morbidity and caregiver burden in parents of children with Tourette’s disorder and psychiatric comorbidity, J Am Acad Child Adolesc Psychiatry, 42, 1370, 10.1097/01.CHI.0000085751.71002.48 · DOI
- Robertson, 2003, Mental and Behavioral Dysfunction in Movement Disorders, 443, 10.1385/1-59259-326-7:443 · DOI
- Grados, 2008, Tourette Syndrome Association International Consortium for Genetics; Latent class analysis of Gilles de la Tourette syndrome using comorbidities: clinical and genetic implications, Biol Psychiatry, 64, 219, 10.1016/j.biopsych.2008.01.019 · DOI
- Cavanna, 2011, Dissecting the Gilles de la Tourette spectrum: a factor analytic study on 639 patients, J Neurol Neurosurg Psychiatry, 82, 1320, 10.1136/jnnp.2010.225029 · DOI
- Rodgers, 2014, Sex-related and non sex-related comorbidity subtypes of tic disorders: a latent class approach, Eur J Neurol, 21, 700, 10.1111/ene.12274 · DOI
- Robertson, 2000, Tourette syndrome, associated conditions and the complexities of treatment, Brain, 123, 425, 10.1093/brain/123.3.425 · DOI · Paper page
- Robertson, 2011, Gilles de la Tourette syndrome: the complexities of phenotype and treatment, Br J Hosp Med, 72, 100, 10.12968/hmed.2011.72.2.100 · DOI · Paper page
- Erenberg, 1987, The natural history of Tourette syndrome: a follow-up study, Ann Neurol, 22, 383, 10.1002/ana.410220317 · DOI · Paper page
- Leckman, 1998, Course of tic severity in Tourette syndrome: the first two decades, Pediatrics, 102, 14, 10.1542/peds.102.1.14 · DOI · Paper page
- Coffey, 2004, Reexamining tic persistence and tic-associated impairment in Tourette’s Disorder findings from a naturalistic follow-up study, J Nerv Ment Dis, 192, 776, 10.1097/01.nmd.0000144696.14555.c4 · DOI · Paper page
- Bloch, 2006, Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette’s syndrome, J Child Psychol Psychiatry, 47, 551, 10.1111/j.1469-7610.2005.01561.x · DOI
- Pappert, 2003, Objective assessments of longitudinal outcome in Gilles de la Tourette’s syndrome, Neurology, 61, 936, 10.1212/01.WNL.0000086370.10186.7C · DOI · Paper page
- Lin, 2007, Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive–compulsive disorder, J Child Psychol Psychiatry, 48, 157, 10.1111/j.1469-7610.2006.01687.x · DOI · Paper page
- Rizzo, 2012, Long term clinical course of Tourette syndrome, Brain Dev, 34, 667, 10.1016/j.braindev.2011.11.006 · DOI
- Ferenczi, 1921, Psychoanalytic observations on tic, Int J Psychoanal, 2, 1
- Mahler, 1943, A psychosomatic study of maladie des tics (Gilles de la Tourette’s Disease), Psychiatr Q, 17, 579, 10.1007/BF01561841 · doi:10.1007/bf01561841
- The Tourette Syndrome Association International Consortium for Genetics, 1999, A complete genome scan in sib-pairs affected with Gilles de la Tourette Syndrome, Am J Hum Gen, 65, 1428, 10.1086/302613 · DOI · Paper page
- Scharf, 2012, Prevalence of Tourette syndrome and chronic tics in the population-based Avon longitudinal study of parents and children cohort, J Am Acad Child Adolesc Psychiatry, 51, 192, 10.1016/j.jaac.2011.11.004 · DOI · Paper page
- Scharf, 2014, Genome-wide association study of Tourette’s syndrome, Mol Psychiatry, 18, 721, 10.1038/mp.2012.69 · DOI · Paper page
- Scharf, 2008, Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample, Neurology, 70, 1495, 10.1212/01.wnl.0000296833.25484.bb · DOI
- Ercan-Sencicek, 2010, L-Histidine decarboxylase and Tourette’s syndrome, N Engl J Med, 362, 1901, 10.1056/NEJMoa0907006 · DOI · Paper page
- Swedo, 1998, Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases, Am J Psychiatry, 155, 264, 10.1176/ajp.155.2.264 · DOI · Paper page
- Murphy, 2004, Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive–compulsive disorder and tics, Biol Psychiatry, 55, 61, 10.1016/S0006-3223(03)00704-2 · DOI
- Kiessling, 1993, Antineuronal antibodies in movement disorders, Pediatrics, 92, 39, 10.1542/peds.92.1.39 · DOI · Paper page
- Kiessling, 1994, Antineuronal antibodies: tics and obsessive–compulsive symptoms, J Dev Behav Pediatr, 15, 421, 10.1097/00004703-199412000-00005 · DOI
- Muller, 2000, Increased anti-streptococcal antibodies in patients with Tourette’s syndrome, Psychiatry Res, 94, 43, 10.1016/S0165-1781(00)00125-6 · DOI
- Muller, 2001, Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette’s syndrome, Psychiatry Res, 101, 187, 10.1016/S0165-1781(01)00215-3 · DOI
- Church, 2003, Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis, J Neurol Neurosurg Psychiatry, 74, 602, 10.1136/jnnp.74.5.602 · DOI · Paper page
- Rizzo, 2006, Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: Controlled cross-sectional study, J Child Neurol, 21, 747, 10.1177/08830738060210091001 · DOI
- Peterson, 2000, Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive–compulsive, and attention deficit/hyperactivity disorders, Arch Gen Psychiatry, 57, 364, 10.1001/archpsyc.57.4.364 · DOI · Paper page
- Singer, 2008, Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections, Pediatrics, 121, 1198, 10.1542/peds.2007-2658 · DOI
- Murphy, 2013, Tourette Syndrome, 168, 10.1093/med/9780199796267.003.0009 · DOI
- Rhee, 2012, Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview, Int J Gen Med, 5, 163, 10.2147/IJGM.S24212 · DOI
- Riedel, 1998, Lyme disease presenting as Tourette’s syndrome, Lancet, 351, 418, 10.1016/S0140-6736(05)78357-4 · DOI
- Court, 2013, One Bite Changed My Life Forever
- Editorial, 2013, Yours Magazine, 20
- Leckman, 2003, Mental and Behavioral Dysfunction in Movement Disorders, 467, 10.1385/1-59259-326-7:467 · doi:10.1385/1-59259-326-7:467
- Pasamanick, 1956, A study of the association of prenatal and paranatal factors with the development of tics in children; a preliminary investigation, J Pediatr, 48, 596, 10.1016/S0022-3476(56)80095-4 · DOI
- Burd, 1999, Prenatal and perinatal risk factors for Tourette disorder, J Perinat Med, 27, 295, 10.1515/jpm.1999.042 · DOI
- Mathews, 2006, Association between maternal smoking and increased symptom severity in Tourette’s syndrome, Am J Psychiatry, 163, 1066, 10.1176/ajp.2006.163.6.1066 · DOI
- Hoekstra, 2013, Tourette Syndrome, 156, 10.1093/med/9780199796267.003.0008 · DOI
- Murphy, 2013, Tourette Syndrome, 439, 10.1093/med/9780199796267.003.0020 · DOI
- Mueller, 2006, Enhanced cognitive control in young people with Tourette’s syndrome, Curr Biol, 16, 570, 10.1016/j.cub.2006.01.064 · DOI · Paper page
- Jackson, 2011, Compensatory neural reorganization in Tourette syndrome, Curr Biol, 21, 580, 10.1016/j.cub.2011.02.047 · DOI
- Greene, 2013, Tourette Syndrome, 238, 10.1093/med/9780199796267.003.0012 · DOI
- Sandor, 2013, Tourette’s with Dignity. Don’t Tic Me Off. The Youthdale Series
- Eddy, 2011, Quality of life in young people with Tourette syndrome: a controlled study, J Neurol, 258, 291, 10.1007/s00415-010-5754-6 · DOI · Paper page
- Storch, 2007, Quality of life in youth with Tourette’s syndrome and chronic tic disorder, J Clin Child Adolesc Psychol, 36, 217, 10.1080/15374410701279545 · DOI · Paper page
- Burd, 1992, Tourette Syndrome and learning-disabilities, J Learn Disabil, 25, 598, 10.1177/002221949202500909 · DOI
- Higgins, 2011, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0
- Guyatt, 2011, GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology, J Clin Epidemiol, 64, 380, 10.1016/j.jclinepi.2010.09.011 · DOI · Paper page
- Shapiro, 1968, Treatment of Gilles de la Tourette’s Syndrome with haloperidol, Br J Psychiatry, 114, 345, 10.1192/bjp.114.508.345 · DOI
- Harris, 2006, Tic disorders: neural circuits, neurochemistry, and neuroimmunology, J Child Neurol, 21, 678, 10.1177/08830738060210080901 · DOI
- Pringsheim, 2011, Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders, Cochrane Database Syst Rev, 4, CD007990, 10.1002/14651858.cd007990.pub2 · DOI · Paper page
- Waldon, 2013, Trials of pharmacological interventions for Tourette syndrome: a systematic review, Behav Neurol, 26, 265, 10.1155/2013/626410 · DOI
- Roessner, 2013, Pharmacological treatment of tic disorders and Tourette Syndrome, Neuropharmacology, 68, 143, 10.1016/j.neuropharm.2012.05.043 · DOI
- Sallee, 1997, Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette’s disorder, Am J Psychiatry, 154, 1057, 10.1176/ajp.154.8.1057 · DOI · Paper page
- Shapiro, 1989, Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette’s syndrome, Arch Gen Psychiatry, 46, 722, 10.1001/archpsyc.1989.01810080052006 · DOI · Paper page
- Shapiro, 1984, Controlled study of pimozide vs. placebo in Tourette’s syndrome, J Am Acad Child Psychiatry, 23, 161, 10.1097/00004583-198403000-00007 · DOI · Paper page
- Dion, 2002, Risperidone in the treatment of Tourette syndrome: A double-blind, placebo-controlled trial, J Clin Psychopharmacol, 22, 31, 10.1097/00004714-200202000-00006 · DOI · Paper page
- Sallee, 2000, Ziprasidone treatment of children and adolescents with Tourette’s syndrome: A pilot study, J Am Acad Child Adolesc Psychiatry, 39, 292, 10.1097/00004583-200003000-00010 · DOI · Paper page
- Gilbert, 2004, Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial, J Am Acad Child Adolesc Psychiatry, 43, 206, 10.1097/00004583-200402000-00017 · DOI
- Bruggeman, 2001, Risperidone versus pimozide in Tourette’s disorder: A comparative double-blind parallel-group study, J Clin Psychiatry, 62, 50, 10.4088/JCP.v62n0111 · DOI · Paper page
- Ross, 1978, A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette’s syndrome, Am J Psychiatry, 135, 585, 10.1176/ajp.135.5.585 · DOI
- Liu, 2011, A multicenter controlled study on aripiprazole treatment for children with Tourette syndrome in China, Zhonghua Er Ke Za Zhi, 49, 572
- Yoo, 2011, Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders, Eur Child Adolesc Psychiatry, 20, 127, 10.1007/s00787-010-0154-0 · DOI
- Gulisano, 2011, Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome, Neurol Sci, 32, 1213, 10.1007/s10072-011-0678-1 · DOI
- Ji, 2005, Olanzapine for treatment of Tourette syndrome: a double-blind randomised controlled trial, Chin J Clin Rehabil, 9, 66
- Fulop, 1987, ECG changes during haloperidol and pimozide treatment of Tourette’s disorder, Am J Psychiatry, 144, 673, 10.1176/ajp.144.5.673 · DOI
- Flockhart, 2000, Studies on the mechanism of a fatal clarithromycin–pimozide interaction in a patient with Tourette syndrome, J Clin Psychopharmacol, 20, 317, 10.1097/00004714-200006000-00005 · DOI
- Goetz, 1987, Clonidine and Gilles de la Tourette’s syndrome: double-blind study using objective rating methods, Ann Neurol, 21, 307, 10.1002/ana.410210313 · DOI · Paper page
- Singer, 1995, The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine, Pediatrics, 95, 74, 10.1542/peds.95.1.74 · DOI · Paper page
- Leckman, 1991, Clonidine treatment of Gilles de la Tourette’s syndrome, Arch Gen Psychiatry, 48, 324, 10.1001/archpsyc.1991.01810280040006 · DOI · Paper page
- Du, 2008, Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders, Aust N Z J Psychiatry, 42, 807, 10.1080/00048670802277222 · DOI · Paper page
- Zhong, 2007, Randomized double-blind controlled study on treatment of tic disorders in children with transcutaneous patch of clonidine, Zhonghua Er Ke Za Zhi, 45, 785
- Gancher, 1990, Treatment of Tourette’s syndrome with transdermal clonidine: a pilot study, J Neuropsychiatry Clin Neurosci, 2, 66, 10.1176/jnp.2.1.66 · DOI
- Scahill, 2001, A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder, Am J Psychiatry, 158, 1067, 10.1176/appi.ajp.158.7.1067 · DOI · Paper page
- Cummings, 2002, Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study, Clin Neuropharmacol, 25, 325, 10.1097/00002826-200211000-00009 · DOI
- Allen, 2005, Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders, Neurology, 65, 1941, 10.1212/01.wnl.0000188869.58300.a7 · DOI · Paper page
- Gadow, 1992, Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings, J Am Acad Child Adolesc Psychiatry, 31, 462, 10.1097/00004583-199205000-00012 · DOI
- Gadow, 2007, Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder, J Am Acad Child Adolesc Psychiatry, 46, 840, 10.1097/chi.0b013e31805c0860 · DOI
- Castellanos, 1997, Controlled stimulant treatment of ADHD and comorbid Tourette’s syndrome: Effects of stimulant and dose, J Am Acad Child Adolesc Psychiatry, 36, 589, 10.1097/00004583-199705000-00008 · DOI · Paper page
- Lyon, 2010, Testing tic suppression: Comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette’s disorder, J Child Adolesc Psychopharmacol, 20, 283, 10.1089/cap.2010.0032 · DOI · Paper page
- Ondo, 2006, Topiramate in essential tremor: a double-blind, placebo-controlled trial, Neurology, 66, 672, 10.1212/01.wnl.0000200779.03748.0f · DOI · Paper page
- Smith-Hicks, 2007, A double blind randomized placebo control trial of levetiracetam in Tourette syndrome, Mov Disord, 22, 1764, 10.1002/mds.21615 · DOI · Paper page
- Awaad, 2009, Levetiracetam in Tourette syndrome: a randomized double blind, placebo controlled study, J Pediatr Neurol, 7, 257
- Jankovic, 2010, A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome, J Neurol Neurosurg Psychiatry, 81, 70, 10.1136/jnnp.2009.185348 · DOI · Paper page
- Feigin, 1996, A controlled trial of deprenyl in children with Tourette’s syndrome and attention deficit hyperactivity disorder, Neurology, 46, 965, 10.1212/WNL.46.4.965 · DOI · Paper page
- Zanettini, 2007, Valvular heart disease and the use of dopamine agonists for Parkinson’s disease, N Engl J Med, 356, 39, 10.1056/NEJMoa054830 · DOI · Paper page
- Schade, 2007, Dopamine agonists and the risk of cardiac-valve regurgitation, N Engl J Med, 356, 29, 10.1056/NEJMoa062222 · DOI · Paper page
- Gilbert, 2000, Tourette’s syndrome improvement with pergolide in a randomized, double-blind, crossover trial, Neurology, 54, 1310, 10.1212/WNL.54.6.1310 · DOI
- Gilbert, 2003, Tic reduction with pergolide in a randomized controlled trial in children, Neurology, 60, 606, 10.1212/01.WNL.0000044058.64647.7E · DOI · Paper page
- Kurlan, 2012, A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette’s syndrome, Mov Disord, 27, 775, 10.1002/mds.24919 · DOI · Paper page
- Nicolson, 2005, A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette’s disorder, J Am Acad Child Adolesc Psychiatry, 44, 640, 10.1097/01.chi.0000163279.39598.44 · DOI · Paper page
- Singer, 2001, Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial, Neurology, 56, 599, 10.1212/WNL.56.5.599 · DOI
- Spencer, 2002, A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder, Arch Gen Psychiatry, 59, 649, 10.1001/archpsyc.59.7.649 · DOI · Paper page
- Rickards, 2012, Treatment practices in Tourette syndrome: the European perspective, Eur J Paediatr Neurol, 16, 361, 10.1016/j.ejpn.2011.12.001 · DOI
- Kurlan, 1993, A pilot controlled study of fluoxetine for obsessive–compulsive symptoms in children with Tourette’s syndrome, Clin Neuropharmacol, 16, 167, 10.1097/00002826-199304000-00009 · DOI
- Scahill, 1997, Fluoxetine has no marked effect on tic symptoms in patients with Tourette’s syndrome: a double-blind placebo-controlled study, J Child Adolesc Psychopharmacol, 7, 75, 10.1089/cap.1997.7.75 · DOI
- Sanberg, 1998, Treatment of Tourette’s syndrome with mecamylamine, Lancet, 352, 705, 10.1016/S0140-6736(05)60822-7 · DOI
- Silver, 2001, Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for tourette’s disorder, J Am Acad Child Adolesc Psychiatry, 40, 1103, 10.1097/00004583-200109000-00020 · DOI · Paper page
- Howson, 2004, Clinical and attentional effects of acute nicotine treatment in Tourette’s syndrome, Eur Psychiatry, 19, 102, 10.1016/j.eurpsy.2003.11.002 · DOI
- Gabbay, 2012, A double-blind, placebo-controlled trial of omega-3 fatty acids in Tourette’s disorder, Pediatrics, 129, e1493, 10.1542/peds.2011-3384 · DOI
- Gaffney, 2002, Risperidone versus clonidine in the treatment of children and adolescents with Tourette’s syndrome, J Am Acad Child Adolesc Psychiatry, 41, 330, 10.1097/00004583-200203000-00013 · DOI · Paper page
- George, 1993, Fluvoxamine and sulpiride in comorbid obsessive–compulsive disorder and Gilles de la Tourette Syndrome, Hum Psychopharmacol, 8, 327, 10.1002/hup.470080505 · DOI
- Hedderick, 2009, Double-Blind, Crossover Study of Clonidine and Levetiracetam in Tourette Syndrome, Pediatric Neurology, 40, 420, 10.1016/j.pediatrneurol.2008.12.014 · DOI · Paper page
- Kang, 2009, Efficacy of clonidine transdermal patch for treatment of Tourette’s syndrome in children, Zhongguo Dang Dai Er Ke Za Zhi, 11, 537
- Carr, 1995, Competing responses for the treatment of Tourette syndrome and tic disorders, Behav Res Ther, 33, 455, 10.1016/0005-7967(94)00066-S · DOI
- Ganos, 2012, Are premonitory urges a prerequisite of tic inhibition in Gilles de la Tourette syndrome?, J Neurol Neurosurg Psychiatry, 83, 975, 10.1136/jnnp-2012-303033 · DOI
- Verdellen, 2011, European clinical guidelines for Tourette Syndrome and other tic disorders. Part III: behavioural and psychosocial interventions, Eur Child Adolesc Psychiatry, 20, 197, 10.1007/s00787-011-0167-3 · DOI · Paper page
- Steeves, 2012, Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation, Can J Psychiatry, 57, 144, 10.1177/070674371205700303 · DOI · Paper page
- Hoogduim, 1998, Exposure and response prevention in the treatment of Gilles de la Tourette’s Syndrome: four case studies, Clin Psychol Psychother, 4, 125, 10.1002/(SICI)1099-0879(199706)4:2<125::AID-CPP125>3.0.CO;2-Z · DOI
- Yates, 1958, The application of learning theory to the treatment of tics, J Abnorm Soc Psychol, 56, 175, 10.1037/h0040699 · DOI · Paper page
- Peterson, 1992, An evaluation of behavioral treatments for Tourette syndrome, Behav Res Ther, 30, 167, 10.1016/0005-7967(92)90140-C · DOI
- Sukhodolsky, 2004, Cognitive-behavioral therapy for anger in children and adolescents: a meta-analysis, Aggress Violent Beh, 9, 247, 10.1016/j.avb.2003.08.005 · doi:10.1016/j.avb.2003.08.005 · Paper page
- Scahill, 2006, Randomized trial of parent management training in children with tic disorders and disruptive behavior, J Child Neurol, 21, 650, 10.1177/08830738060210080201 · DOI · Paper page
- Barkley, 2002, Psychosocial treatments for attention-deficit/hyperactivity disorder in children, J Clin Psychiatry, 63, 36
- Wilhelm, 2012, Randomized trial of behavior therapy for adults with Tourette syndrome, Arch Gen Psychiatry, 69, 795, 10.1001/archgenpsychiatry.2011.1528 · DOI · Paper page
- Wilhelm, 2003, Habit reversal versus supportive psychotherapy for Tourette’s disorder: a randomized controlled trial, Am J Psychiatry, 160, 1175, 10.1176/appi.ajp.160.6.1175 · DOI · Paper page
- Azrin, 1990, Treatment of Tourette Syndrome by habit reversal: a waiting-list control group comparison, Behav Ther, 21, 305, 10.1016/S0005-7894(05)80333-8 · DOI · Paper page
- Azrin, 1980, Habit reversal vs negative practice treatment of nervous tics, Behav Ther, 11, 169, 10.1016/S0005-7894(80)80017-7 · DOI · Paper page
- Verdellen, 2004, Exposure with response prevention versus habit reversal in Tourette’s syndrome: A controlled study, Behav Res Ther, 42, 501, 10.1016/S0005-7967(03)00154-2 · DOI · Paper page
- Himle, 2012, A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders, Behav Res Ther, 50, 565, 10.1016/j.brat.2012.05.009 · DOI · Paper page
- Bergin, 1998, Relaxation therapy in Tourette syndrome: a pilot study, Pediatr Neurol, 18, 136, 10.1016/S0887-8994(97)00200-2 · DOI
- Sukhodolsky, 2009, Randomized trial of anger control training for adolescents with Tourette’s syndrome and disruptive behavior, J Am Acad Child Adolesc Psychiatry, 48, 413, 10.1097/CHI.0b013e3181985050 · DOI · Paper page
- Woods, 2011, Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning, J Child Neurol, 26, 858, 10.1177/0883073810397046 · DOI · Paper page
- Anderson, 2006, Surgery insight: Deep brain stimulation for movement disorders. Nature clinical practice, Neurology, 2, 310, 10.1038/ncpneuro0193 · DOI
- Cavanna, 2011, An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspective, Br J Neurosurg, 25, 38, 10.3109/02688697.2010.534200 · DOI
- Lyons, 2011, Deep brain stimulation: current and future clinical applications, Mayo Clinic Proc, 86, 662, 10.4065/mcp.2011.0045 · DOI · Paper page
- Vandewalle, 1999, Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus, Lancet, 353, 724, 10.1016/S0140-6736(98)05964-9 · DOI · Paper page
- Piedad, 2012, What patients with Gilles de la tourette syndrome should be treated with deep brain stimulation and what is the best target?, Neurosurgery, 71, 173, 10.1227/NEU.0b013e3182535a00 · DOI
- Hariz, 2010, Gilles de la Tourette syndrome and deep brain stimulation, Eur J Neurosci, 32, 1128, 10.1111/j.1460-9568.2010.07415.x · DOI
- Mink, 2006, Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome, Mov Disord, 21, 1831, 10.1002/mds.21039 · DOI · Paper page
- Muller-Vahl, 2011, European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation, Eur Child Adolesc Psychiatry, 20, 209, 10.1007/s00787-011-0166-4 · DOI
- Edwards, 2008, Clinical applications of transcranial magnetic stimulation in patients with movement disorders, Lancet Neurol, 7, 827, 10.1016/S1474-4422(08)70190-X · DOI
- Gilbert, 2004, Should transcranial magnetic stimulation research in children be considered minimal risk?, Clin Neurophysiol, 115, 1730, 10.1016/j.clinph.2003.10.037 · DOI
- Hoekstra, 2002, Is Tourette’s syndrome an autoimmune disease?, Mol Psychiatry, 7, 437, 10.1038/sj.mp.4000972 · DOI
- Hoekstra, 2004, Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study, J Clin Psychiatry, 65, 537, 10.4088/JCP.v65n0413 · DOI
- Kivity, 2010, Evidence for the use of intravenous immunoglobulins – a review of the literature, Clin Rev Allergy Immunol, 38, 201, 10.1007/s12016-009-8155-9 · DOI
- Anton, Botulinum toxins: Adverse effects, Adverse Drug React Bull, 1027, 10.1097/FAD.0b013e328346f575 · doi:10.1097/fad.0b013e328346f575
- Bloch, 2008, Emerging treatment for Tourette’s disorder, Curr Psychiatry Rep, 10, 323, 10.1007/s11920-008-0052-z · DOI
- Berardelli, 1997, Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Ital Soc Neurol, 18, 261, 10.1007/BF02083302 · DOI
- Simpson, 2008, Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 70, 1699, 10.1212/01.wnl.0000311389.26145.95 · DOI · Paper page
- Cui, 2009, Acupuncture for Gilles de la Tourette’s syndrome, Cochrane Database Syst Rev, CD007832, 10.1002/14651858.cd007832 · DOI
- Ackermans, 2011, Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome, Brain, 134, 832, 10.1093/brain/awq380 · DOI · Paper page
- Welter, 2008, Internal pallidal and thalamic stimulation in patients with Tourette syndrome, Arch Neurol, 65, 952, 10.1001/archneur.65.7.952 · DOI · Paper page
- Maciunas, 2007, Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome, J Neurosurg, 107, 1004, 10.3171/JNS-07/11/1004 · DOI · Paper page
- Orth, 2005, Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome, Clin Neurophysiol, 116, 764, 10.1016/j.clinph.2004.10.003 · DOI · Paper page
- Chae, 2004, A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette’s syndrome, Cogn Behav Neurol, 17, 109, 10.1097/01.wnn.0000116253.78804.3a · DOI
- Munchau, 2002, Repetitive transcranial magnetic stimulation for Tourette syndrome, Neurology, 59, 1789, 10.1212/01.WNL.0000036615.25044.50 · DOI
- Marras, 2001, Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial, Neurology, 56, 605, 10.1212/WNL.56.5.605 · DOI · Paper page
- Chi, 2003, Clinical study on treatment of tourette’s syndrome with acupuncture-Chinese herbs combination, Journal of Acupuncture and Tuina Science, 1, 15, 10.1007/BF02845419 · doi:10.1007/bf02845419
- Kurlan, 1998, Tourette’s syndrome and ‘PANDAS’: will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection, Neurology, 50, 1530, 10.1212/WNL.50.6.1530 · DOI
- Kurlan, 2004, The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive–compulsive symptoms: hypothesis or entity? Practical considerations for the clinician, Pediatrics, 113, 883, 10.1542/peds.113.4.883 · DOI · Paper page
- Garvey, 1999, A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections, Biol Psychiatry, 45, 1564, 10.1016/S0006-3223(99)00020-7 · DOI · Paper page
- Elliott, 2013, Talking About Medicines (Tabs): Involving Children and Young People With Chronic Illness in Managing Their Medicines. Final Report
- Rivera-Navarro, 2009, The diagnosis of Tourette’s Syndrome: communication and impact, Clin Child Psychol Psychiatry, 14, 13, 10.1177/1359104508100127 · DOI
- Mol Debes, 2008, Limited knowledge of Tourette syndrome causes delay in diagnosis, Neuropediatrics, 39, 101, 10.1055/s-2008-1081457 · doi:10.1055/s-2008-1081457
- Kompoliti, 2006, Gilles de la Tourette syndrome: Patient’s knowledge and concern of adverse effects, Mov Disord, 21, 248, 10.1002/mds.20680 · doi:10.1002/mds.20680
- Woods, 2010, Behavior Therapy for Tourette’s Disorder: Utilization in a Community Sample and an Emerging Area of Practice for Psychologists, Prof Psychol Res Pr, 41, 518, 10.1037/a0021709 · DOI · Paper page
- Conelea, 2011, Exploring the impact of chronic tic disorders on youth: results from the Tourette Syndrome Impact Survey, Child Psychiatry Hum Dev, 42, 219, 10.1007/s10578-010-0211-4 · DOI · Paper page
- Leckman, 1989, The Yale Global Tic Severity Scale – Initial testing of a clinician-rated scale of tic severity, J Am Acad Child Adolesc Psychiatry, 28, 566, 10.1097/00004583-198907000-00015 · DOI · Paper page
200 of 206 shown
Cited by
Gilles de la Tourette syndrome
Robertson, M. M., Eapen, V., Singer, H. S., Martino, D., Scharf, J. M., Paschou, P., Roessner, V., Woods, D. W., Hariz, M., Mathews, C. A., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.97 · Cited by 347
Self-citationAndrén, P., Jakubovski, E., Murphy, T. L., Woitecki, K., Tarnok, Z., Zimmerman-Brenner, S., van de Griendt, J., Debes, N. M., Viefhaus, P., Robinson, S., et al. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01845-z · Cited by 225
Self-citationCoghill, D., Banaschewski, T., Cortese, S., Asherson, P., Brandeis, D., Buitelaar, J., Daley, D., Danckaerts, M., Dittmann, R. W., Doepfner, M., et al. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01871-x · Cited by 180
Self-citationGreenberg, E., Albright, C., Hall, M., Hoeppner, S., Miller, S., Farley, A., Silverman, M., Braddick, V., Sprich, S., & Wilhelm, S. (2023) · Behavior Therapy · doi:10.1016/j.beth.2022.07.007 · Cited by 11
Comparing similar and dissimilar competing responses for Tic management
Goldman, K. J., Simpson Martin, H., & DeLeon, I. G. (2025) · Behavioral Interventions · doi:10.1002/bin.2068 · Cited by 1
Metadata
- Authors
- Hollis, C., Pennant, M., Cuenca, J., Glazebrook, C., Kendall, T., Whittington, C., Stockton, S., Larsson, L., Bunton, P., Dobson, S., Groom, M., Hedderly, T., Heyman, I., Jackson, G. M., Jackson, S., Murphy, T., Rickards, H., Robertson, M., & Stern, J.
- Venue
- Health Technology Assessment
- Published
- 2016-01
- Volume
- 20
- Issue
- 4
- Pages
- 1-450
- ISSN
- 1366-5278
- 2046-4924
- Cited by
- 119
- References
- 14
- Language
- en
- Funders
- Health Technology Assessment programme (10/142/01)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis. https://app.cochat.ai/papers/10.3310/hta20040
- The paper
- Hollis, C., Pennant, M., Cuenca, J., Glazebrook, C., Kendall, T., Whittington, C., Stockton, S., Larsson, L., Bunton, P., Dobson, S., Groom, M., Hedderly, T., Heyman, I., Jackson, G. M., Jackson, S., Murphy, T., Rickards, H., Robertson, M., & Stern, J. (2016). Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis. Health Technology Assessment. https://doi.org/10.3310/hta20040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.